Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Biochemistry ; 55(13): 1977-88, 2016 Apr 05.
Artigo em Inglês | MEDLINE | ID: mdl-26959335

RESUMO

We have examined the abilities of three complementary γ-peptide nucleic acid (γPNA) oligomers to invade an RNA G-quadruplex and potently inhibit translation of a luciferase reporter transcript containing the quadruplex-forming sequence (QFS) within its 5'-untranslated region. All three γPNA oligomers bind with low nanomolar affinities to an RNA oligonucleotide containing the QFS. However, while all probes inhibit translation with low to midnanomolar IC50 values, the γPNA designed to hybridize to the first two G-tracts of the QFS and adjacent 5'-overhanging nucleotides was 5-6 times more potent than probes directed to either the 3'-end or internal regions of the target at 37 °C. This position-dependent effect was eliminated after the probes and target were preincubated at an elevated temperature prior to translation, demonstrating that kinetic effects exert significant control over quadruplex invasion and translation inhibition. We also found that antisense γPNAs exhibited similarly potent effects against luciferase reporter transcripts bearing QFS motifs having G2, G3, or G4 tracts. Finally, our results indicate that γPNA oligomers exhibit selectivity and/or potency higher than those of other antisense molecules such as standard PNA and 2'-OMe RNA previously reported to target G-quadruplexes in RNA.


Assuntos
Desenho de Fármacos , Quadruplex G/efeitos dos fármacos , Oligonucleotídeos Antissenso/farmacologia , Biossíntese de Proteínas/efeitos dos fármacos , Inibidores da Síntese de Proteínas/farmacologia , RNA Mensageiro/antagonistas & inibidores , Regiões 5' não Traduzidas/efeitos dos fármacos , Motivos de Aminoácidos , Animais , GTP Fosfo-Hidrolases/genética , Genes Reporter/efeitos dos fármacos , Glicina/análogos & derivados , Glicina/química , Humanos , Cinética , Proteínas de Membrana/genética , Conformação de Ácido Nucleico , Desnaturação de Ácido Nucleico , Inibidores da Síntese de Proteínas/química , Inibidores da Síntese de Proteínas/metabolismo , Estabilidade de RNA/efeitos dos fármacos , RNA Mensageiro/química , RNA Mensageiro/metabolismo , Coelhos , Reticulócitos/enzimologia , Reticulócitos/metabolismo
2.
Foodborne Pathog Dis ; 8(5): 643-6, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21214372

RESUMO

The antibacterial activity of an herbal combination composed of Mume Fructus, Coptidis Rhizoma, and Schizandrae Fructus extracts on enterohemorrhagic Escherichia coli (EHEC) was evaluated in the present study. The combination demonstrated antibacterial activity against all EHEC strains tested in this study, including those resistant to multiple antibiotics; minimum inhibitory concentration values ranged from 0.49 to 31.25 mg/mL. In in vivo antibacterial activity assay, the herbal combination was administered to mice after initial E. coli O157 infection and had significant effects on mouse mortality. The effects of the herbal combination on Shiga toxin release from EHEC O26, EHEC O111, and EHEC O157 strains containing the stx1 and stx2 genes were assessed by the reversed passive latex agglutination method, and there was no increased Shiga toxin release in the strain cultures containing the herbal combination. These results suggested that the herbal combination may be a safe and effective remedy for EHEC inhibition.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Escherichia coli Êntero-Hemorrágica/efeitos dos fármacos , Fitoterapia , Extratos Vegetais/farmacologia , Prunus/química , Schisandra/química , Animais , Coptis chinensis , Combinação de Medicamentos , Farmacorresistência Bacteriana Múltipla , Medicamentos de Ervas Chinesas/uso terapêutico , Escherichia coli Êntero-Hemorrágica/enzimologia , Escherichia coli Êntero-Hemorrágica/patogenicidade , Infecções por Escherichia coli/tratamento farmacológico , Infecções por Escherichia coli/microbiologia , Infecções por Escherichia coli/mortalidade , Proteínas de Escherichia coli/metabolismo , Feminino , Testes de Fixação do Látex , Camundongos , Camundongos Endogâmicos BALB C , Testes de Sensibilidade Microbiana , Extratos Vegetais/uso terapêutico , Plantas Medicinais/química , Reação em Cadeia da Polimerase , Inibidores da Síntese de Proteínas/metabolismo , Toxinas Shiga/metabolismo , Resultado do Tratamento
3.
Biochemistry ; 45(11): 3692-702, 2006 Mar 21.
Artigo em Inglês | MEDLINE | ID: mdl-16533052

RESUMO

In the course of a microbial product screening aimed at the discovery of novel antibiotics acting on bacterial protein synthesis, a complex of three structurally related tetrapeptides, namely, GE81112 factors A, B, and B1, was isolated from a Streptomyces sp. The screening was based on a cell-free assay of bacterial protein synthesis driven by a model mRNA containing natural initiation signals. In this study we report the production, isolation, and structure determination of these novel, potent and selective inhibitors of cell-free bacterial protein synthesis, which stably bind the 30S ribosomal subunit and inhibit the formation of fMet-puromycin. They did not inhibit translation by yeast ribosomes in vitro. Spectroscopic analyses revealed that they are tetrapeptides constituted by uncommon amino acids. While GE81112 factors A, B, and B1 were effective in inhibiting bacterial protein synthesis in vitro, they were less active against Gram-positive and Gram-negative bacterial cells. Cells grown in minimal medium were more susceptible to the compounds than those grown in rich medium, and this is most likely due to competition or regulation by medium components during peptide uptake. The novelty of the chemical structure and of the specific mode of action on the initiation phase of bacterial protein synthesis makes GE81112 a unique scaffold for designing new drugs.


Assuntos
Proteínas de Bactérias/antagonistas & inibidores , Peptídeos/farmacologia , Inibidores da Síntese de Proteínas/farmacologia , Streptomyces/metabolismo , Antibacterianos/metabolismo , Antibacterianos/farmacologia , Anti-Infecciosos/farmacologia , Proteínas de Bactérias/metabolismo , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos/métodos , Escherichia coli/metabolismo , Espectroscopia de Ressonância Magnética , Modelos Moleculares , Iniciação Traducional da Cadeia Peptídica/efeitos dos fármacos , Peptídeos/química , Peptídeos/metabolismo , Biossíntese de Proteínas , Inibidores da Síntese de Proteínas/metabolismo , RNA Mensageiro/metabolismo , Ribossomos/metabolismo , Fatores de Tempo
4.
Eur J Biochem ; 271(12): 2350-60, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15182350

RESUMO

Leaves of mistletoe (Viscum album L) contain three toxic lectins (type 2 ribosome-inactivating proteins) MLI, MLII, and MLIII, differing in molecular mass and carbohydrate specificity. Clones, containing sequences of three gene variants designated ml1p, ml2p, and ml3p, were obtained using PCR amplification from cDNA and from mistletoe genomic DNA. The quantitative ratio of the ml1p, ml2p, and ml3p genes in genomic DNA was found to be 1.5 : 1 : 4, respectively, whereas the ratio of their mRNA was 50 : 10 : 1. The quantitative prevalence of the ml1p transcript correlates well with the observation that MLI is quantitatively dominant over MLII and MLIII in the mistletoe extract. The sequences of the proteins encoded by the ml1p, ml2p, and ml3p genes are identical to MLI by 98, 88, and 77%, respectively. The similarity to MLI of the amino acid sequence encoded by the gene ml1p, the quantitative prevalent of its mRNA, as well as structural properties of the B-chain indicate that the gene, ml1p, corresponds to MLI. Western blot analysis of recombinant A-chains encoded by the three variants of mlp genes with the monoclonal antibody MNA4 having differential affinity to MLI, MLII and MLIII A-chains suggests that the ml2p and ml3p genes correspond to MLII and MLIII, respectively. Structural differences in the carbohydrate-binding sites of the B-subunits of ML1p, ML2p, and ML3p probably explain the difference in sugar specificity of MLI, MLII and MLIII.


Assuntos
Erva-de-Passarinho/química , Lectinas de Plantas/genética , Lectinas de Plantas/metabolismo , Preparações de Plantas/metabolismo , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo , Toxinas Biológicas/genética , Toxinas Biológicas/metabolismo , Sequência de Aminoácidos , Clonagem Molecular , Erva-de-Passarinho/genética , Dados de Sequência Molecular , Família Multigênica , Folhas de Planta/química , Lectinas de Plantas/toxicidade , Preparações de Plantas/toxicidade , Proteínas de Plantas/toxicidade , Subunidades Proteicas/química , Subunidades Proteicas/genética , Subunidades Proteicas/metabolismo , Inibidores da Síntese de Proteínas/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Proteínas Inativadoras de Ribossomos Tipo 2 , Ricina/genética , Alinhamento de Sequência , Toxinas Biológicas/toxicidade
5.
Exp Neurol ; 184(2): 1010-6, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14769395

RESUMO

The sleep disorder narcolepsy may now be considered a neurodegenerative disease, as there is a massive reduction in the number of neurons containing the neuropeptide, hypocretin (HCRT). Most narcoleptic patients have low to negligible levels of HCRT in the cerebrospinal fluid (CSF), and such measurements serve as an important diagnostic tool. However, the relationship between HCRT neurons and HCRT levels in CSF in human narcoleptics is not known and cannot be directly assessed. To identify this relationship in the present study, the neurotoxin, hypocretin-2-saporin (HCRT2-SAP), was administered to the lateral hypothalamus (LH) to lesion HCRT neurons. CSF was extracted at circadian times (ZT) 0 (time of lights-on) or ZT8 at various intervals (2, 4, 6, 12, 21, 36, 60 days) after neurotoxin administration. Compared to animals given saline in the LH, rats with an average loss of 73% of HCRT neurons had a 50% decline in CSF HCRT levels on day 60. The decline in HCRT levels was evident by day 6 and there was no recovery or further decrease. The decline in HCRT was correlated with increased REM sleep. Lesioned rats that were kept awake for 6 h were not able to release HCRT to match the output of saline rats. As most human narcoleptics have more than 80% reduction of CSF HCRT, the results from this study lead us to conclude that in these patients, virtually all of the HCRT neurons might be lost. In those narcoleptics where CSF levels are within the normal range, it is possible that not all of the HCRT neurons are lost and that the surviving HCRT neurons might be increasing output of CSF HCRT.


Assuntos
Hipotálamo/fisiopatologia , Narcolepsia/fisiopatologia , Neurônios/fisiologia , Neuropeptídeos/líquido cefalorraquidiano , Animais , Ritmo Circadiano/fisiologia , Hipotálamo/efeitos dos fármacos , Hipotálamo/patologia , Imunotoxinas , Injeções Intraventriculares , Peptídeos e Proteínas de Sinalização Intracelular , Masculino , Narcolepsia/induzido quimicamente , Degeneração Neural/induzido quimicamente , Degeneração Neural/fisiopatologia , Proteínas do Tecido Nervoso , Neurônios/efeitos dos fármacos , Neurônios/patologia , Neuropeptídeos/administração & dosagem , Neuropeptídeos/metabolismo , Receptores de Orexina , Orexinas , Proteínas de Plantas , Inibidores da Síntese de Proteínas/administração & dosagem , Inibidores da Síntese de Proteínas/metabolismo , Ratos , Ratos Sprague-Dawley , Receptores Acoplados a Proteínas G , Receptores de Neuropeptídeos/metabolismo , Proteínas Inativadoras de Ribossomos Tipo 1 , Saporinas , Privação do Sono/fisiopatologia , Sono REM/efeitos dos fármacos , Sono REM/fisiologia , Toxinas Biológicas
6.
Eur J Cell Biol ; 81(10): 529-38, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12437187

RESUMO

Ricin and viscumin are heterodimeric protein toxins. Their A-chain is enzymatically active and removes an adenine residue from the 28S rRNA, the B-chain has lectin activity and binds to terminal galactose residues of cell surface receptors. The toxins reveal a high degree of identity in their amino acid sequences. Nevertheless, uptake into 3T3 cells occurs via different receptors and endocytotic pathways. This has been revealed by enzyme linked based analysis of ricin competition with viscumin, and by fluorochrome-labeled toxins (viscumin-FITC, ricin-Alexa 568), which were added simultaneously or separately to living cells. Then the uptake was followed by confocal laser scanning microscopy. Ricin immediately is delivered to the tubular and vesicular structures of endosomes in the perinuclear area while viscumin becomes endocytosed into small vesicles preferentially in the cell periphery. After about 60 min both these toxins may be found in tubo-vesicular structures of endosomes where the sorting process can directly be observed. The fact that this sorting takes place is a strong argument for the assumption that the toxins are bound to membrane proteins, either to their original receptors or to other proteins inside the endosomal compartment exhibiting terminal galactose residues. The toxins are biologically fully active as has been proven by binding and by toxicity experiments, thus the differences in targeting do not arise from labeling.


Assuntos
Endocitose/efeitos dos fármacos , Endossomos/efeitos dos fármacos , Células Eucarióticas/efeitos dos fármacos , Preparações de Plantas/farmacologia , Proteínas de Plantas , Inibidores da Síntese de Proteínas/farmacologia , Ricina/farmacologia , Toxinas Biológicas/farmacologia , Vesículas Transportadoras/efeitos dos fármacos , Células 3T3 , Animais , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Membrana Celular/ultraestrutura , Endocitose/fisiologia , Endossomos/metabolismo , Endossomos/ultraestrutura , Células Eucarióticas/citologia , Células Eucarióticas/metabolismo , Imunofluorescência , Complexo de Golgi/efeitos dos fármacos , Complexo de Golgi/metabolismo , Complexo de Golgi/ultraestrutura , Membranas Intracelulares/efeitos dos fármacos , Membranas Intracelulares/metabolismo , Membranas Intracelulares/ultraestrutura , Lisossomos/efeitos dos fármacos , Lisossomos/metabolismo , Lisossomos/ultraestrutura , Camundongos , Preparações de Plantas/metabolismo , Inibidores da Síntese de Proteínas/metabolismo , Receptores da Transferrina/efeitos dos fármacos , Receptores da Transferrina/metabolismo , Proteínas Inativadoras de Ribossomos Tipo 2 , Ricina/metabolismo , Fatores de Tempo , Toxinas Biológicas/metabolismo , Vesículas Transportadoras/metabolismo , Vesículas Transportadoras/ultraestrutura
7.
Poult Sci ; 80(5): 615-20, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11372711

RESUMO

In a preliminary experiment, the inclusion of vitamin K1 (K1) at a dietary level of 0.1 mg/kg was as effective as 1 or 2 mg/kg in reducing plasma prothrombin time (PT). To obtain an estimate of the dietary K1 requirement and to compare the biopotency of different vitamin K sources for poults, three additional experiments were conducted. In Experiment 1, an incomplete factorial arrangement of treatments was used in which five dietary concentrations of K1 (0, 0.1, 0.25, 0.5, or 2.0 mg/kg) were tested and two concentrations of neomycin (0 or 75 mg/L) in drinking water were used in conjunction with 0, 0.1, and 0.5 mg of K1/kg of diet. Thus, we used a total of eight treatments. Each treatment was given to two pens of poults, with eight poults per pen. Prothrombin time and prothrombin concentration (PC) in plasma were not influenced by inclusion of neomycin in drinking water. The K1 requirement was estimated, on the basis of PT and PC, to be 0.099 and 0.13 mg/kg, respectively, in Experiment 1. Dietary K1 concentrations tested in Experiment 2 were 0, 0.08, 0.31, or 0.44 mg/kg. A similar protocol to that of Experiment 1 was used in this experiment. The results of Experiment 2 indicated that the dietary K1 requirement was 0.079 mg, based on the influence of dietary K1 on PT. In Experiment 3, dietary treatments consisted of the equivalent of 0.22, 0.55, or 1.11 microM of menadione equivalent/kg from vitamin K1, menadione dimethypyrimidinol bisulfite (MPB) or menadione nicotinamide bisulfite (MNB), respectively, and a control without supplementation of any vitamin K source. The results of Experiment 3 showed that the biopotency of K1 was greater than that of MPB or MNB. The biopotencies of MPB and MNB were similar, although MNB was more potent in reducing plasma PT when supplemented at the level of 0.1 mg of menadione/kg. A nadir of PT and a plateau of PC were evident with a dietary supplementation of MPB or MNB at a level of 0.25 mg of menadione/kg. Results of this research show that the dietary K1 requirement of young turkeys is in the range of 0.079 to 0.13 mg/kg, and ingestion of neomycin did not affect estimates of the requirement. The biopotency of vitamin K1 in reducing plasma PT and increasing plasma PC was greater than that of MPB or MNB. The biopotency of MNB was greater than that of MPB when menadione supplementation was equivalent to 0.10 mg of K1/kg.


Assuntos
Neomicina/administração & dosagem , Niacinamida/análogos & derivados , Inibidores da Síntese de Proteínas/administração & dosagem , Perus/crescimento & desenvolvimento , Vitamina K 1/administração & dosagem , Vitamina K/análogos & derivados , Ração Animal , Fenômenos Fisiológicos da Nutrição Animal , Animais , Disponibilidade Biológica , Galinhas , Suplementos Nutricionais , Relação Dose-Resposta a Droga , Masculino , Neomicina/metabolismo , Necessidades Nutricionais , Inibidores da Síntese de Proteínas/metabolismo , Protrombina/análise , Tempo de Protrombina/veterinária , Perus/fisiologia , Vitamina K 1/análogos & derivados , Vitamina K 1/metabolismo , Vitamina K 3
8.
J Antibiot (Tokyo) ; 53(8): 807-15, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11079803

RESUMO

A strain that produces new lipopeptide antibiotics is a new species of the genus Actinoplanes for which we propose the name Actinoplanes friuliensis (type strain: HAG 010964). The strain is an actinoplanete actinomycete having cell wall II composition and forming sporangia. Comparisons with Actinoplanes spp. which have similarities with our isolate, including fatty acid analysis, showed that the isolate belongs to a new species. Taxonomic studies and fermentation are presented.


Assuntos
Actinomycetales/classificação , Actinomycetales/metabolismo , Antibacterianos/farmacologia , Inibidores da Síntese de Proteínas/farmacologia , Actinomycetales/fisiologia , Antibacterianos/metabolismo , Avaliação Pré-Clínica de Medicamentos/métodos , Ácidos Graxos/metabolismo , Fermentação , Testes de Sensibilidade Microbiana , Peptidoglicano/biossíntese , Peptidoglicano/efeitos dos fármacos , Inibidores da Síntese de Proteínas/metabolismo
9.
Mol Cells ; 10(3): 331-7, 2000 Jun 30.
Artigo em Inglês | MEDLINE | ID: mdl-10901172

RESUMO

We purified and partially sequenced a cytostatic protein from the ASC-17D Sertoli cell-conditioned media (rSCCM) showing a molecular weight of 90 kDa with homodimeric composition. N-terminal amino acid analysis revealed that the protein was homologous to the arginine deiminase (ADI) of Mycoplasma arginini. We found ADI enzyme activity in rSCCM and the abolishment of the growth inhibitory effect by the supplement of L-arginine. Thus, we confirmed that the cytostatic activity in rSCCM was due to the depletion of extracellular L-arginine by ADI. Apparent increase of cell death or DNA fragmentation was not observed in DU145 cells cultured in the presence of ADI. Incubation of DU145 cancer cells with taxol resulted in a marked DNA fragmentation, whereas pretreatment with ADI or cycloheximide protected the cells from taxol-induced apoptosis. Preincubation of the cells with ADI inhibited S35-methionine incorporation into protein synthesis in a dose dependent manner. These data suggest that ADI-induced arginine depletion may inhibit protein synthesis, and result in the protection of apoptotic cell death that requires new protein synthesis.


Assuntos
Apoptose/efeitos dos fármacos , Citoproteção , Hidrolases/metabolismo , Paclitaxel/farmacologia , Neoplasias da Próstata/patologia , Sequência de Aminoácidos , Animais , Arginina/metabolismo , Astrócitos/efeitos dos fármacos , Astrócitos/metabolismo , Linhagem Celular , Meios de Cultivo Condicionados , Cicloeximida/farmacologia , Fragmentação do DNA , Fase G1 , Humanos , Hidrolases/química , Hidrolases/farmacologia , L-Lactato Desidrogenase/metabolismo , Lipopolissacarídeos/farmacologia , Masculino , Dados de Sequência Molecular , Óxido Nítrico/metabolismo , Neoplasias da Próstata/química , Neoplasias da Próstata/metabolismo , Inibidores da Síntese de Proteínas/metabolismo , Ratos , Alinhamento de Sequência , Células de Sertoli/metabolismo , Células Tumorais Cultivadas
10.
Biochem Biophys Res Commun ; 264(3): 944-8, 1999 Nov 02.
Artigo em Inglês | MEDLINE | ID: mdl-10544035

RESUMO

Recombinant mistletoe lectin (rML) belongs to the class of type II ribosome-inactivating proteins (RIP) composed of a catalytically active A-chain with rRNA N-glycosidase activity and a B-chain with carbohydrate binding properties. To investigate the contribution of the enzymatic activity of the rML A-chain to the observed cytotoxic and apoptotic effects, an rMLA E166Q R169Q molecule was developed by means of site-specific mutagenesis. Following heterologous expression, the activity of mutant rMLA was measured in a cell-free assay for rRNA-N-glycosidase activity. Moreover, after generation of heterodimer, the activities of mutant rML E166Q R169Q and rML wild type were determined in a cytotoxicity and apoptosis assay. Although the reduction of activity as measured in the cell-free RIP assay was more pronounced (factor 237) than in both cellular assays (factors 20-22), the data clearly indicate a close correlation between cytotoxicity, apoptosis, and the enzymatic activity of the rML A-chain. Thus, RIP activity is an essential feature of rML and therefore a prerequisite for its biological function as an anticancer agent.


Assuntos
Apoptose/genética , Lectinas/genética , Preparações de Plantas , Proteínas de Plantas , Toxinas Biológicas/genética , Lectinas/metabolismo , Erva-de-Passarinho , Mutagênese Sítio-Dirigida , Lectinas de Plantas , Plantas Medicinais , Inibidores da Síntese de Proteínas/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Ribonucleosídeos/genética , Ribonucleosídeos/metabolismo , Proteínas Inativadoras de Ribossomos Tipo 2 , Ribossomos , Toxinas Biológicas/metabolismo
12.
Biochem Biophys Res Commun ; 229(1): 287-94, 1996 Dec 04.
Artigo em Inglês | MEDLINE | ID: mdl-8954120

RESUMO

The enzymatic mechanism of a small ribosome-inactivating protein, gamma-momorcharin, purified from the seeds of Momordica charantia, has been characterized. By SDS-polyacrylamide and electrospray ionization mass spectrometry, its molecular weight was measured to be 11,500 daltons which is much lower than other RIPs known to date. It can inhibit the protein synthesis in the rabbit reticulocyte cell-free system with ID50 of 55 nM. When rat liver ribosome was incubated with gamma-momorcharin, a diagnostic RNA fragment appeared on the gel after rRNAs were treated with acid aniline. Sequencing of the RNA fragment indicates that the action site of gamma-momorcharin in 28S ribosomal RNA of rat liver is at a specific adenosine (position 4324), which is in a highly conserved loop of 28S rRNA.


Assuntos
N-Glicosil Hidrolases/metabolismo , Proteínas de Plantas/metabolismo , Plantas Medicinais/enzimologia , Inibidores da Síntese de Proteínas/metabolismo , RNA Ribossômico 28S/metabolismo , Proteínas Ribossômicas , Relação Dose-Resposta a Droga , N-Glicosil Hidrolases/farmacologia , Proteínas de Plantas/farmacologia , Biossíntese de Proteínas/efeitos dos fármacos , Inibidores da Síntese de Proteínas/farmacologia , Proteínas Inativadoras de Ribossomos , Ribossomos/efeitos dos fármacos , Sementes/química , Especificidade por Substrato
13.
Mol Biol (Mosk) ; 25(2): 422-30, 1991.
Artigo em Russo | MEDLINE | ID: mdl-1881395

RESUMO

A comparative study of gelonin and A-chains of ricin, mistletoe lectin I and diphtheria toxin was undertaken. The effect of pH was studied on: a) the conformation of the proteins under study using intrinsic fluorescence; b) interaction of these proteins with ricin B-chain using gel-filtration. Structural stability of the proteins was assessed according to denaturing action of guanidine hydrochloride and temperature, and localization of tryptophan residues was determined using fluorescence quenching by I-, Cs+ and acrylamide. All investigated proteins were shown to undergo the conformational changes when a environment became acidic. In comparison with an intact protein--gelonin, the A-chains of ricin, a mistletoe lectin and a diphtheria toxin are less stable. At pH less than 5.0 tryptophan residues became more accessible to quencher and a positive charge of the surrounding area increases (in the case of gelonin it is negatively charged). No reliable interaction of a ricin B-chain with both gelonin and A-chain of diphtheria toxin was observed. The interaction of a ricin B-chain with a A-chain of mistletoe lectin I is weaker than that with ricin A-chain and is practically pH-independent.


Assuntos
Preparações de Plantas , Inibidores da Síntese de Proteínas/metabolismo , Ricina/metabolismo , Toxinas Biológicas/metabolismo , Catálise , Cromatografia em Gel , Toxina Diftérica/metabolismo , Concentração de Íons de Hidrogênio , Concentração Osmolar , Proteínas de Plantas/metabolismo , Proteínas Inativadoras de Ribossomos Tipo 1 , Proteínas Inativadoras de Ribossomos Tipo 2 , Espectrometria de Fluorescência , Temperatura , Triptofano
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA